Diltiazem (hydrochloride)


CAS No. : 33286-22-5

(Synonyms: CRD-401)

33286-22-5
Price and Availability of CAS No. : 33286-22-5
Size Price Stock
500mg $55 In-stock
1g $66 In-stock
5g $145 In-stock
10 g Get quote
50 g Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-14656
M.Wt: 450.98
Formula: C22H27ClN2O4S
Purity: >98 %
Solubility: H2O : 33.33 mg/mL (ultrasonic)
Introduction of 33286-22-5 :

Diltiazem hydrochloride (CRD-401) is a calcium antagonist with vasodilatory activity. Diltiazem hydrochloride inhibits Ca2+ mobilization/influx, norepinephrine-induced contraction, and depolarization. Diltiazem hydrochloride produces coronary vasodilation and renal vasodilation; it inhibits sodium reabsorption in the distal nephron and increases urine flow, sodium and potassium excretion, Inulin (HY-N7075) and PAH clearance, and free water clearance. Diltiazem hydrochloride can be used in research related to cardiovascular diseases and kidney diseases[1][2][3]. In Vitro:Diltiazem hydrochloride (CRD-401) produces stronger inhibition of nerve-evoked contractions than of direct muscle-evoked contractions in rabbit mesenteric and pulmonary arteries, reducing the pulmonary nerve response to 10% of control[3].
Diltiazem hydrochloride reduces depolarization-induced contraction in voltage-clamped rabbit main pulmonary artery[3].
Diltiazem hydrochloride reduces norepinephrine-induced contraction of rabbit main pulmonary artery and inhibits norepinephrine-induced depolarization[3].
Diltiazem hydrochloride increases the K+-induced mechanical threshold in rabbit main pulmonary arteries and reduces K+-induced contraction[3]. In Vivo:Diltiazem hydrochloride (CRD-401) (3 µg/kg; intra-arterial administration; single injection) produces a stronger and longer-lasting coronary vasodilator effect than its l-isomer in anesthetized dogs[1].
Diltiazem hydrochloride (1-30 μg/kg/min; continuous intrarenal arterial infusion) increases urine flow, sodium excretion, and renal blood flow under saline and water diuresis conditions, and increases glomerular filtration rate under saline loading but not under water diuresis conditions[2].
Diltiazem hydrochloride (10 μg/kg/min; continuous intrarenal arterial infusion) increases sodium excretion even when renal blood flow is maintained constant by aortic clamping; and it reduces sodium reabsorption in the distal nephron[2].
Diltiazem hydrochloride (CRD-401) (1-100 μg/kg; intrarenal arterial bolus injection; intravenous bolus injection; continuous intrarenal arterial infusion) increases renal blood flow through direct renal vasodilation[2].

Your information is safe with us.